Genetics in Parkinson’s Disease – Lessons from a Global Cohort
Watch Dr. Peter Bauer, MD, Chief Scientific Officer at CENTOGENE, as he discusses the genetics of Parkinson’s Disease (PD) and outlines genetic screening options for PD. You will also gain insights into the Rostock International Parkinson’s Disease Study (ROPAD) – a global observational study that is investigating the genetic background of PD patients for better diagnosis and treatment.
- Parkinson’s Disease and genetics of PD
- Genetic screening for an adult-onset disease
- ROPAD: CENTOGENE’s global PD genetic screening program
- Insights from global PD populations
Dr. Peter Bauer Chief Scientific Officer
Dr. Peter Bauer, MD serves as CENTOGENE’s Chief Scientific Officer, where he combines clinical and medical understanding in genetic testing with an excellent knowledge of the latest scientific development, based on his extraordinary experience especially in high-throughput genetic testing using next-generation sequencing.
Dr. Bauer received his board certification in Human Genetics in 2006 and headed the molecular diagnostic laboratory at the Institute of Medical Genetics and Applied Genomics at the University Hospital Tübingen. Moreover, he is Vice President of the German Society of Neurogenetics (DGNG). Peter has authored more than 140 publications in neurogenetics, oncogenetics, cardiogenetics and sequencing technology.